Pharmaceuticals · US
Top 10 Pharmaceuticals markets in the US
The fastest-growing and largest of the 20 sized Pharmaceuticals markets in the US, 2023 to 2033, with active clinical trials.
Top 10 Pharmaceuticals markets in the USThe fastest-growing and largest of the 20 sized Pharmaceuticals markets in the US, 2023 to 2033, with active clinical trials.
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Biosimilars | $15.5 Bn | $121.8 Bn | 22.9% | – |
| 2 | Cell Based Immunotherapy | $7 Bn | $46.9 Bn | 21% | – |
| 3 | Cannabidiol (CBD) | $9.3 Bn | $36.8 Bn | 14.8% | – |
| 4 | Cannabis | $14.2 Bn | $42.3 Bn | 11.5% | – |
| 5 | Atopic Dermatitis Drugs | $4.7 Bn | $12.5 Bn | 10.2% | – |
| 6 | Oncology/Cancer Drugs | $74.3 Bn | $138.2 Bn | 6.4% | – |
| 7 | Anti-Aging | $37 Bn | $67 Bn | 6.1% | – |
| 8 | Diabetes Management | $32.8 Bn | $53.9 Bn | 5.1% | – |
| 9 | Alzheimer Drugs | $2.1 Bn | $3.4 Bn | 4.8% | – |
| 10 | Contraceptives Drugs | $10.6 Bn | $16.9 Bn | 4.8% | – |
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Oncology/Cancer Drugs | $74.3 Bn | $138.2 Bn | 6.4% | – |
| 2 | Anti-Aging | $37 Bn | $67 Bn | 6.1% | – |
| 3 | Diabetes Management | $32.8 Bn | $53.9 Bn | 5.1% | – |
| 4 | Gastrointestinal Drugs | $22.7 Bn | $29.3 Bn | 2.6% | – |
| 5 | Asthma & COPD Drugs | $20.8 Bn | $25.3 Bn | 2% | – |
| 6 | Biosimilars | $15.5 Bn | $121.8 Bn | 22.9% | – |
| 7 | Cannabis | $14.2 Bn | $42.3 Bn | 11.5% | – |
| 8 | HIV Drugs | $12.6 Bn | $18.3 Bn | 3.8% | – |
| 9 | Contraceptives Drugs | $10.6 Bn | $16.9 Bn | 4.8% | – |
| 10 | Cancer Supportive Care Drugs | $10.4 Bn | $13.6 Bn | 2.7% | – |
2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running.
Biosimilars grows fastest, at 22.9% a year from 2023 to 2033, ahead of Cell Based Immunotherapy (21%).
Oncology/Cancer Drugs is the largest, worth about $74.3 Bn in 2023 and $138.2 Bn by 2033 (projected).
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.
Canada